Member Info for MisterPositive

FDA approved and with the IND in place in USA, this could go bonkers if any US Big Pharma keeping an eye on Japan trials wants a piece of this cake. This could go global in very short space of time. Off course US Big Pharma might have to fight it off with the Japanese Pharma. Remember the tussle recently by Japanese major Takeda to win Shire multi Billion takeover.

Yep. Bring on the results... Buying the dip. Can see multiple £££s on good results. This is more than just a punt with Japanese specialist Pharma partner onboard paying all development costs in addition to Eur 5m payment to FARN. Expanding its reach to Japan, Korea and possibly China.

GWMO just crashed -53%....WTF Hope nobody was holding that one.

Lakshmi, Never2 heard such tosh... ...Phase 2 holds little significance.... Are you for real ? Go and tell that to Big Pharma. May be they doing something wrong...lol

Lakshmi, No body said it's going to £8.50 overnight. But can sure get to multiple £££s on results. But this is very low in MCap terms given the advance stage of drugs here.

That is tiny....no wonder we cannot buy any decent Qty at times.

Response was slightly inconsistent, not the results which were good. I think Company wanted even better numbers. Why else do you think Japanese specialist Pharma would sign up for such a good deal if Traumakine results were bad and take it further to Phase III? Think about it. PLUS. Faron Pharma now firing ahead with Clevegen also.

Slightly incorrect I think. Ernest Giles had gold samples with decent grades that many thought were good, but there was no JORC in place. Still Newmont walked away. Forget about consensus on LSE bulletin board, who said what. People need to be aware of risks. We don't have any idea of the resource here coz we have not drilled. All good having numbers quoted in Moyes report, but until the prospects are drilled, we don't know what we got....that is the simple fact. We are all speculating and taking risk on accordingly including myself.

* €5 million in development payments. * Double digit Royalties * 1/3 profits from future sales This is a great deal. Coverage in both Japan, Korea. China market next....

Tomie, Full credit to you on the excellent find. Deal terms are Excellent. Want to buy more....tried 5 times, but no stock

Jeeezzzz, Just looked at 52 week high 890p......WTF. before that drop that was simply overdone I think.

VCB, Agree. We do not know deal terms and are all speculating. All depends if the major asks BPC for upfront costs for say 20% of the first drill OR will they carry us through for 1st drill only? What deal split do folks expect here. 80/20 75/25

Tommie, Thanks. Deal terms look good. Bought some. Hope not too high entry.,,

in my view. Agree. Before price would not budge on Buys. MMs ready to take it up I think. Just bit more Buying and we should see. Plus news due soon on 'Multiple' fronts.

From RNS... ...."Analyses are ongoing to understand the underlying causes of the inconsistent biomarker response of the Traumakine treatment group"... * why inconsistent response? Cannot see any follow up / update from the company?

Orslega, Agree. With $90 oil price, MYN profits would be much higher also. As Warren buffet said: "Be greedy when others are fearful"... Works all the time...

Spike912, You have a point about NDA. That's probably why they paying monthly fee to keep competition out.

and MCap £56m.....come on. This price is a steal. In 3 months you purchase today might look like an absolute bargain. With upto 23 Billion barrels recoverable in play, had to buy some more here.

If you get a good deal in the first place, you won't need another bidder in my opinion.

Buy the dip here should yield handsome rewards in coming days/weeks. Can see easy +100% return from current low price.